[Erythrocyte filterability and treatment with pentoxifylline]
- PMID: 6673029
[Erythrocyte filterability and treatment with pentoxifylline]
Abstract
The purpose of our study was to verify the possibility of obtaining a reduction in the erythrocyte filtration rate and an improvement in the O2 tissue uptake in twenty patients suffering from insulin-dependent diabetes mellitus and diabetic angiopathy, randomly divided in two groups receiving pentoxifylline (1,200 mg/day for 30 days) or a placebo solution, respectively. The erythrocyte filtration rate decreased in patients treated with pentoxifylline and the difference of erythrocyte filtration rate between the two groups was statistically significant.
Similar articles
-
Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.Pharmatherapeutica. 1987;5(1):26-39. Pharmatherapeutica. 1987. PMID: 3602021
-
Study on relationship between erythrocyte filtration and other risk factors in diabetic angiopathy.Ric Clin Lab. 1981;11 Suppl 1:317-26. Ric Clin Lab. 1981. PMID: 7188119
-
[Use of erythrocyte filtration in the study of diabetic vasculopathy. Therapeutic efficacy of pentoxifylline].Clin Ter. 1983 Jul 15;106(1):19-25. Clin Ter. 1983. PMID: 6627879 Italian. No abstract available.
-
Clinical considerations and treatment of diabetic angiopathy.J Med. 1979;10(5):365-79. J Med. 1979. PMID: 393791 Review. No abstract available.
-
[The biology of fibrinogen. The role of pentoxifylline].J Mal Vasc. 1989;14 Suppl A:25-8. J Mal Vasc. 1989. PMID: 2654312 Review. French.